Capillus272™ OfficePro Receives FDA Clearance
Miami, Florida (PRWEB) June 10, 2015 -- Capillus, LLC, receives 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Capillus272™ OfficePro, an in-office laser hair therapy product proven to prevent hair loss and promote hair regrowth in adults who suffer with androgenic alopecia. A Miami-based medical device manufacturer, Capillus represents a large and international network of dermatologists, surgeons, and hair loss clinics committed to providing only safest and most effective clinical strength hair loss treatments.
Today, the company is pleased to announce clearance for the Capillus272™ OfficePro, a new medical product designed to help physicians guide men and women along their journey to a fuller head of natural hair.
“Physicians love the OfficePro because it introduces patients to laser hair therapy in the office,” explains Carlos Piña, Capillus CEO. “It is a wonderful tool for physicians to build a relationship with patients while administering treatment and monitoring results.”
Laser therapy has a history of use in treating arthritis, chronic inflammation, and skin disorders since the mid 1960s. Today, medical products like the Capillus272™ OfficePro leverage the power of laser therapy to increase circulation, cellular metabolism, and hair growth in individuals who suffer with androgenic alopecia, or hair loss.
“The clearance substantiates what we have known and experienced clinically,” explains Dr. Shelly Friedman, Capillus Medical Director. “Capillus is very successful in converting fine, vellus hairs to normal growing hairs.” In fact, an independently reviewed study of the Capillus272 laser cap revealed a 51% increase in hair counts among men and women participating in the study.
Bridging the Gap
Not all men and women are candidates for hair restoration. While some are opposed to surgery, many others are skeptical of at-home treatments where success relies on consistent and disciplined product use. The Capillus272™ OfficePro bridges the gap between physicians and non-candidates, providing a safe and non-invasive treatment option that is ideal for nearly every patient case.
After just a few weeks of treatment, LLLT stimulation from the OfficePro has demonstrated the capability to increase hair growth by improving circulation and cellular metabolism in and around hair follicles. Patient confidence and scalp health improve over time, enabling physicians to recommend additional procedures in the future, like hair transplant and at-home laser therapy.
Learn More About Capillus272™ OfficePro
Physicians are invited to log on to http://www.capillus.com to learn more about treating hair loss with Capillus272™ OfficePro. To speak with a Capillus representative, call 1-888-272-9599.
Frances Pina-Brea, Capillus, LLC, http://www.capillus.com, +1 888-272-9599, [email protected]
Share this article